Q1 2023 Holdings
Filed 2023-05-15 | 8 holdings | $207.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Eqrx, Inc. | COM | 26886C107 | $70.5M | 36,335,375 | 34.0% |
| Denali Therapeutics, Inc.(DNLI) | COM | 24823R105 | $59.2M | 2,568,749 | 28.6% |
| Erasca, Inc.(ERAS) | COM | 29479A108 | $33.3M | 11,055,554 | 16.1% |
| Verve Therapeutics, Inc. | COM | 92539P101 | $29.0M | 2,008,809 | 14.0% |
| Karuna Therapeutics, Inc. | COM | 48576A100 | $5.4M | 30,000 | 2.6% |
| Singular Genomics Systems, Inc. | COM | 82933R100 | $4.6M | 3,798,926 | 2.2% |
| Natera, Inc.(NTRA) | COM | 632307104 | $3.6M | 64,441 | 1.7% |
| Unity Biotechnology, Inc.(UNBX) | COM | 91381U200 | $1.6M | 1,004,817 | 0.8% |